News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,381 Results
Type
Article (41996)
Company Profile (290)
Press Release (687085)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (206325)
Career Advice (2384)
Deals (35802)
Drug Delivery (110)
Drug Development (82064)
Employer Resources (175)
FDA (16561)
Job Trends (15038)
News (349563)
Policy (33179)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2628)
Accelerated approval (31)
Adcomms (24)
Allergies (141)
Alliances (50100)
ALS (168)
Alzheimer's disease (1677)
Antibody-drug conjugate (ADC) (305)
Approvals (16827)
Artificial intelligence (506)
Autoimmune disease (143)
Automation (37)
Bankruptcy (362)
Best Places to Work (11708)
BIOSECURE Act (20)
Biosimilars (190)
Biotechnology (186)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (636)
Cancer (4786)
Cardiovascular disease (398)
Career advice (1977)
Career pathing (35)
CAR-T (277)
CDC (44)
Celiac Disease (2)
Cell therapy (732)
Cervical cancer (36)
Clinical research (70034)
Collaboration (1688)
Company closure (4)
Compensation (1138)
Complete response letters (52)
COVID-19 (2734)
CRISPR (89)
C-suite (820)
Cystic fibrosis (143)
Data (6190)
Decentralized trials (2)
Denatured (25)
Depression (132)
Diabetes (497)
Diagnostics (6773)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (244)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (226)
Earnings (90510)
Editorial (55)
Employer branding (21)
Employer resources (153)
Events (118626)
Executive appointments (965)
FDA (19661)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1458)
Gene editing (195)
Generative AI (44)
Gene therapy (594)
GLP-1 (969)
Government (4785)
Grass and pollen (7)
Guidances (384)
Healthcare (19158)
HIV (55)
Huntington's disease (45)
IgA nephropathy (82)
Immunology and inflammation (247)
Immuno-oncology (56)
Indications (104)
Infectious disease (2994)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (244)
Interviews (403)
IPO (16775)
IRA (49)
Job creations (3673)
Job search strategy (1673)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (546)
Leadership (30)
Legal (8030)
Liver cancer (92)
Longevity (14)
Lung cancer (642)
Lymphoma (374)
Machine learning (42)
Management (60)
Manufacturing (779)
MASH (163)
Medical device (13933)
Medtech (13985)
Mergers & acquisitions (20091)
Metabolic disorders (1257)
Multiple sclerosis (155)
NASH (17)
Neurodegenerative disease (309)
Neuropsychiatric disorders (86)
Neuroscience (2895)
Neurotech (1)
NextGen: Class of 2026 (6624)
Non-profit (4558)
Now hiring (65)
Obesity (590)
Opinion (257)
Ovarian cancer (164)
Pain (197)
Pancreatic cancer (226)
Parkinson's disease (285)
Partnered (33)
Patents (488)
Patient recruitment (476)
Peanut (56)
People (59377)
Pharmaceutical (66)
Pharmacy benefit managers (29)
Phase 1 (21848)
Phase 2 (30840)
Phase 3 (22931)
Pipeline (5100)
Policy (278)
Postmarket research (2586)
Preclinical (9299)
Press Release (64)
Prostate cancer (235)
Psychedelics (47)
Radiopharmaceuticals (278)
Rare diseases (819)
Real estate (6003)
Recruiting (69)
Regulatory (24695)
Reports (51)
Research institute (2426)
Resumes & cover letters (410)
Rett syndrome (28)
RNA editing (17)
RSV (76)
Schizophrenia (147)
Series A (243)
Series B (185)
Service/supplier (13)
Sickle cell disease (95)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3655)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (987)
Venture capital (86)
Weight loss (378)
Women's health (87)
Worklife (18)
Date
Last 7 days (597)
Last 30 days (2102)
Last 365 days (30020)
2026 (2837)
2025 (30472)
2024 (35494)
2023 (40435)
2022 (51588)
2021 (56153)
2020 (54533)
2019 (47171)
2018 (35494)
2017 (32561)
2016 (31900)
2015 (38005)
2014 (31704)
2013 (26756)
2012 (29001)
2011 (29766)
2010 (27698)
Location
Africa (783)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39751)
Australia (6602)
California (11199)
Canada (3257)
China (1087)
Colorado (472)
Connecticut (471)
Delaware (333)
Europe (87619)
Florida (1667)
Georgia (355)
Hawaii (3)
Idaho (61)
Illinois (860)
India (63)
Indiana (514)
Iowa (23)
Japan (418)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1376)
Massachusetts (8045)
Michigan (321)
Minnesota (624)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2981)
New Mexico (28)
New York (2964)
North Carolina (1439)
North Dakota (10)
Northern California (5445)
Ohio (332)
Oklahoma (21)
Oregon (41)
Pennsylvania (2257)
Puerto Rico (22)
Rhode Island (47)
South America (1156)
South Carolina (65)
South Dakota (1)
Southern California (4362)
Tennessee (172)
Texas (1726)
United States (39748)
Utah (334)
Vermont (1)
Virginia (261)
Washington D.C. (82)
Washington State (923)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
729,381 Results for "gel e inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
December 10, 2025
·
3 min read
Press Releases
TYBR Health Announces First U.S. Clinical Use of the B3 GEL™ System
January 6, 2026
·
3 min read
Press Releases
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
December 17, 2025
·
6 min read
Press Releases
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 21, 2025
·
14 min read
Press Releases
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
December 16, 2025
·
7 min read
Press Releases
Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)
Thomas Smeenk, BA, unveils a proposed conformal invariant, A = E/(hv), explored as a potential bridge between General Relativity, Quantum Mechanics, cosmology, and string theory.
December 11, 2025
·
9 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025
October 17, 2025
·
4 min read
Rare diseases
Harmony Freezes Cannabidiol Gel After Phase III Miss in Fragile X Syndrome
Harmony Biosciences has paused a mid-stage trial of ZYN002 in 22q11.2 deletion syndrome after the THC-free cannabinoid drug failed to significantly improve social avoidance in a late-stage study in fragile X Syndrome.
November 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
August 25, 2025
·
7 min read
Press Releases
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
November 24, 2025
·
3 min read
1 of 72,939
Next
